Flashpoint Therapeutics Appoints Barry Labinger as Chief Executive Officer
EVANSTON, Ill.--(BUSINESS WIRE)--Jul 28, 2025-- Flashpoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision-engineered structural nanomedicines, today announced the appointment of Barry Labinger as Chief Executive …